Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary liver tumors.

W Y Lau1

  • 1Department of Surgery, Chinese University of Hong Kong, Shatin, New Territories. josephlau@uchk.edu.hk

Seminars in Surgical Oncology
|December 29, 2000
PubMed
Summary
This summary is machine-generated.

Treatment for primary liver tumors, particularly hepatocellular carcinoma, has advanced. Surgical resection remains key for curable tumors, while new therapies emerge for advanced stages, requiring further study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Infantile to late adulthood onset facioscapulohumeral dystrophy type 1: a case series.

Hong Kong medical journal = Xianggang yi xue za zhi·2021
Same author

Immune-mediated necrotising myopathy is a rare statin-associated adverse effect: a case report.

Hong Kong medical journal = Xianggang yi xue za zhi·2020
Same author

Prognostic model for identifying candidates for hepatectomy among patients with hepatocellular carcinoma and hepatic vein invasion.

The British journal of surgery·2020
Same author

Impact of postoperative infective complications on long-term survival after liver resection for hepatocellular carcinoma.

The British journal of surgery·2019
Same author

Severe hemodynamic instability during elective surgery for a patient with a giant pheochromocytoma: A case report.

International journal of surgery case reports·2019
Same author

Multicentre study of the prognostic impact of preoperative bodyweight on long-term prognosis of hepatocellular carcinoma.

The British journal of surgery·2018
Same journal

Preoperative chemoradiation for locally advanced rectal cancer: rationale, technique, and results of treatment.

Seminars in surgical oncology·2003
Same journal

Preoperative chemoradiation for locally advanced rectal adenocarcinoma-the University of Florida experience.

Seminars in surgical oncology·2003
Same journal

Postoperative adjuvant therapy for pancreatic cancer.

Seminars in surgical oncology·2003
Same journal

Conformal chemoradiation for primary and metastatic liver malignancies.

Seminars in surgical oncology·2003
Same journal

Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer.

Seminars in surgical oncology·2003
Same journal

Combined modality therapy in esophageal cancer: the Memorial experience.

Seminars in surgical oncology·2003
See all related articles

Area of Science:

  • Hepatology
  • Surgical Oncology
  • Gastroenterology

Background:

  • Primary liver tumors, especially hepatocellular carcinoma, have seen significant therapeutic advancements.
  • Surgical resection is the primary treatment for resectable hepatocellular carcinoma, offering curative potential.

Purpose of the Study:

  • To review current and emerging treatment modalities for primary liver tumors.
  • To highlight the role of surgery, local ablation, and systemic therapies.
  • To emphasize the need for randomized studies to validate treatment efficacy.

Main Methods:

  • Review of existing literature on primary liver tumor treatments.
  • Discussion of surgical techniques including partial hepatectomy, total hepatectomy, and transplantation.
  • Exploration of palliative resections, tumor debulking, and local ablative therapies.

Related Experiment Videos

  • Consideration of emerging treatments like hepatic artery transcatheter interventions and systemic therapies.

    • Main Results:

    • Partial hepatectomy is the mainstay for resectable hepatocellular carcinoma.
    • Liver transplantation and palliative resections are viable options for select patients.
    • Local ablative therapies benefit patients with small tumors and comorbidities.
    • New systemic and transcatheter therapies show promise for advanced disease.

    Conclusions:

    • Surgical resection remains the cornerstone for curable primary liver tumors.
    • A range of treatments exist, from surgery to local ablation and systemic therapies.
    • Further randomized controlled trials are essential to establish the definitive role of various treatment modalities.